De Arriba F, Ortuño F, Rivera J, Heras I, Funes C, Moraleda J M, Vicente V
Servicio de Hematología, Hospital Virgen del Rosell, Cartagena.
Med Clin (Barc). 1995 Jan 21;104(2):41-4.
The aim of the present study was to investigate the characteristics of the mobilization of hematopoietic precursor cells CD34+ in peripheral blood following stimulation with recombinant granulocytic colony stimulating factor (G-CSF).
Fourteen patients (10 males, 4 females: mean age 33 years; range 14-58 years) diagnosed with oncohematologic neoplasms, in complete remission were studied. The patients had not received antineoplastic for at least four weeks prior to inclusion in the study. Recombinant G-CSF (8 micrograms/kg) was administered subcutaneously over a minimum of 4 days. Peripheral blood control were performed prior to administration of G-CSF (day 0), the third (day +3) day, and the sixth day (day +6). Daily leukapheresis was initiated at day +3 in 5 patients and at day +4 in 9 patients. The CD34+ cell content was determined in both peripheral blood and leukapheretic material by flow cytometry with an anti CD-34 monoclonal antibody conjugated with fluorescein.
No significant differences were observed between the mononuclear cells and CD34+ counts obtained at the first apheresis and those performed at days +3 or +4 (32 +/- 14 x 10(9) vs 29 +/- 19 x 10(9) and 240 +/- 125 x 10(6) vs 162 +/- 160 x 10(6), respectively). The content of the apheresis products in CD34+ cells correlated positively with the number of these cells circulating in peripheral blood (r = 0.53, p = 0.001). In the second apheresis, the presence of mononuclear cells decreased approximately 20% with respect to the first, remained constant in later collections. To the contrary, a constant maintained decrease was observed in the collection of CD34+ on each leukaphesis in that the fourth apheresis only contributed in approximately 10% of the total quantity of CD34+ cells collected.
Maximum mobilization of precursor cells was achieved on the third day at a dosage of 8 micrograms/kg/day, with the data found suggesting that three leukapheretic procedures are enough to collect most of the CD34+ cells mobilized.
本研究旨在探讨重组粒细胞集落刺激因子(G-CSF)刺激后外周血中造血前体细胞CD34+的动员特征。
对14例诊断为血液肿瘤且处于完全缓解期的患者(10例男性,4例女性;平均年龄33岁;年龄范围14 - 58岁)进行研究。患者在纳入研究前至少四周未接受过抗肿瘤治疗。重组G-CSF(8微克/千克)皮下注射至少4天。在注射G-CSF前(第0天)、第三天(第 +3天)和第六天(第 +6天)进行外周血检测。5例患者在第 +3天开始每日进行白细胞分离术,9例患者在第 +4天开始。通过使用与荧光素偶联的抗CD - 34单克隆抗体的流式细胞术测定外周血和白细胞分离材料中的CD34+细胞含量。
首次采集的单个核细胞和CD34+细胞计数与第 +3天或第 +4天采集的结果之间未观察到显著差异(分别为32±14×10⁹ 对29±19×10⁹ 和240±125×10⁶ 对162±160×10⁶)。白细胞分离产物中CD34+细胞的含量与外周血中循环的这些细胞数量呈正相关(r = 0.53,p = 0.001)。在第二次采集时,单个核细胞的数量相对于第一次减少了约20%,在随后的采集中保持稳定。相反,每次白细胞分离术中CD34+细胞的采集量持续下降,第四次采集仅贡献了所采集的CD34+细胞总量的约10%。
在剂量为8微克/千克/天的情况下,第三天实现了前体细胞的最大动员,研究数据表明三次白细胞分离程序足以采集大部分动员的CD34+细胞。